Foundation Medicine (FMI) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts FMI Hot Sheet
Join SI Premium – FREE
Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.39 million.
For earnings history and earnings-related data on Foundation Medicine (FMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- StoneX Reiterates Buy Rating on Marcus Corp. (MCS)
- Standard Motor Products CFO to resign, interim replacement named
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
